Search CommunityWalk:


Anjin Group, Inc.

10 Chilhowie ct.
Cockeysville, MD 21030, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Anjin Group, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted therapies to treat a variety of cancers and immune disorders using a class of drugs known as fusion protein toxins or targeted toxins.

Anjin's research and development center has expertise in the design and development of targeted toxins. These proteins are created by using genetic engineering to splice two genes, each encoding a separate protein, together to create a fusion gene. The fusion gene encodes a new protein which is highly effective at recognizing, binding to and causing the death of the targeted cells. The company has employed a modified diphtheria toxin ("DT") as a platform to develop its targeted toxins. It is also involved in improving the side effect profile of therapies. The company's different targeting and dosing regimens, combined with more complete molecular characterization of tumors in cancer patients, allows for specific tailoring of therapy using multiple targeted toxins to put a disease in remission.

Anjin has partnership with The Leukemia & Lymphoma Society.